Original document(27 pages)  中文版
    The invention discloses a hybridomas cell strain BDD073 CGMCC No.1537 and its produced monoclonal antibody of antihuman VEGFR-3. The heavy chain variable area of the monoclonal antibody has amino acid residue sequence of SEQ ID No.1 or dose displacement, deletion or adding to one to ten amino acid residues of the amino acid residue sequence of SEQ ID No.1 with antihuman VEGFR-3 inactivating active polypeptide; the light chain variable area has amino acid residue sequence of SEQ ID No.2 or dose displacement, deletion or adding to one to ten amino acid residues of the amino acid residue sequence of SEQ ID No.2 with antihuman VEGFR-3 inactivating active polypeptide.
Application Number
申请号
200510127745 Application Date
申请日
2005.12.05
Title 名称 Hybridoma cell strain and its produced human VEGFR-3 resistant monoclonal antibody
Publication Number
公开号
1800373 Publication Date
公开日
2006.07.12
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C12N5/12,C12N5/18,C07K16/18,C12N15/13,C12N15/63,A61K39/395,A61P35/04,A61P9/00
Applicant(s) Name
申请人
Radiology Institute of PLA Military Medical Academy of Sciences
Address 地址 100085
Inventor(s) Name 发明人 Sun Qihong, Chen Hao, Gao Yuan, Gao Jianen
Attorney & Agent 代理人 lu bing

  
Preparation method of anticell or tissue protein mono clone antibody stock
Recombinant gene engineered strain of aujeszkys disease-porcine reproductive and respirator syndrome virus and its uses
Recombinant adenovirus of porcine reproductive and respirator syndrome virus and porcine Circovirus, and vaccine
Recombinant T4 phage for displaying influenza virus non-structural protein NS1 and its uses
Superoxide dismutase extraction method
Thermostable tyrosine phosphatase , and its separation and purification method
Method for preparing pancreatic kallikrein using expanded bed adsorption technology and affinity chromatography
Chymosin powder preparation method
Preparation method of carrageeenen immobilized microbe cell spherical granule and its uses
Recombinant human hepassocin preparation method and its uses in preparing medicine for anti-liver injury
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.